Maria Chiara Rossi Selected Research

Maria Chiara Rossi Research Topics

Disease

23	Type 2 Diabetes Mellitus (MODY) 03/2024 - 12/2008
13	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 08/2009
11	Body Weight (Weight, Body) 03/2024 - 08/2009
6	Weight Gain 01/2023 - 12/2008
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2020 - 08/2013
3	Hyperglycemia 10/2018 - 08/2017
2	Gestational Diabetes (Gestational Diabetes Mellitus) 09/2021 - 01/2015
2	Non-alcoholic Fatty Liver Disease 01/2017 - 01/2016
2	Weight Loss (Weight Reduction) 08/2009 - 12/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	COVID-19 12/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Insulin Resistance 01/2022
1	Overweight 01/2021
1	Infections 01/2021
1	Heart Failure 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Eye Diseases (Eye Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Proteinuria 02/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Chronic Renal Insufficiency 11/2017
1	Abdominal Obesity 01/2017
1	Albuminuria 09/2015
1	Chronic Disease (Chronic Diseases) 09/2015
1	Stillbirth 01/2015
1	Disease Progression 12/2008

Drug/Important Bio-Agent (IBA)

12	Insulin (Novolin)FDA Link 03/2024 - 12/2008
10	Blood Glucose (Blood Sugar)IBA 03/2024 - 08/2010
9	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2015
9	insulin degludecIBA 04/2023 - 08/2017
7	Insulin Glargine (Lantus)FDA Link 04/2023 - 08/2013
5	LipidsIBA 10/2023 - 08/2010
5	InsulinsIBA 04/2023 - 12/2018
5	LDL CholesterolIBA 01/2022 - 01/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2024 - 08/2009
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2017
2	Glucagon-Like Peptide-1 ReceptorIBA 03/2024 - 11/2023
2	semaglutideIBA 01/2022 - 01/2022
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2021
2	CarbohydratesIBA 04/2020 - 08/2013
2	CholesterolIBA 01/2019 - 11/2018
2	Uric Acid (Urate)IBA 01/2019 - 11/2017
2	Liraglutide FDA Link 11/2018 - 08/2009
2	HDL CholesterolIBA 01/2017 - 01/2016
2	insulin receptor-related receptor (IRR)IBA 10/2015 - 01/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2024
1	IDegLiraIBA 03/2024
1	lixisenatideIBA 01/2023
1	dulaglutideIBA 01/2022
1	Tuberculin (PPD)IBA 09/2021
1	picolinic acid (chromium picolinate)IBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	SodiumIBA 01/2021
1	Short-Acting InsulinIBA 10/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 02/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018
1	antineoplaston A10 (A 10)IBA 01/2017
1	AlbuminsIBA 01/2016
1	oxidized low density lipoproteinIBA 09/2015
1	CreatinineIBA 09/2015
1	insulin glulisine FDA Link 08/2013
1	IncretinsIBA 12/2008

Therapy/Procedure

6	Therapeutics 12/2022 - 12/2008
5	Glycemic Control 10/2022 - 09/2015
2	Injections 02/2020 - 12/2008
1	Surgical Amputation (Amputations) 01/2021
1	Nutritional Support (Artificial Feeding) 06/2018
1	Enteral Nutrition (Feeding, Tube) 06/2018
1	Parenteral Nutrition 06/2018
1	Polypharmacy 10/2015